Selectivity of class-III antiarrhythmic action of clofilium in guinea pig ventricular myocytes

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 3, 1996, Pages 401-410

  Li, Qi ^a   Himmel, Herbert M ^a   Ravens, Ursula ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Calcium current; Class III antiarrhythmic action; Clofilium; Delayed rectifier current; Guinea pig ventricular myocytes; Inward rectifier current; Selectivity; Sodium current

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; ANTIARRHYTHMIC AGENT; CLOFILIUM; POTASSIUM CHANNEL; SODIUM CHANNEL;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CALCIUM CURRENT; CONCENTRATION RESPONSE; GUINEA PIG; HEART MUSCLE CELL; INOTROPISM; MEMBRANE CURRENT; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; SODIUM CURRENT;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CALCIUM CHANNELS; GUINEA PIGS; HEART VENTRICLES; POTASSIUM CHANNELS; QUATERNARY AMMONIUM COMPOUNDS; SODIUM CHANNELS;

EID: 0030032313     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199603000-00013     Document Type: Article

References (38)

1. Steinberg MI, Molloy BB. Clofilium - a new antifibrillatory agent that selectively increases cellular refractoriness. Life Sci 1979;25:1397-406.
2. Vaughan-Williams EM. Classification of antiarrhythmic drugs. Pharmacol Ther [B] 1975;1:115-38.
3. Steinberg MI, Smallwood JK. Clofilium and other class-III agents. In: Vaughan-Williams EM, Campbell TJ, eds. Handbook of experimental pharmacology. New York: Springer, 1989;89:389-412.
4. Greene HL, Werner JA, Gross BW, Sears GK, Trobaugh GB, Cobb LA. Prolongation of cardiac refractory times in man by clofilium phosphate, a new antiarrhythmic agent. Am Heart J 1983;106:492-501.
5. Platia EV, Reid PR. Dose-ranging studies of clofilium, an antiarrhythmic quaternary ammonium compound. Clin Pharmacol Ther 1984;35:193-202.
6. Steinberg MI, Sullivan ME, Wiest SA, Rockhold FW, Molloy BB. Cellular electrophysiology of clofilium, a new anti- fibrillatory agent, in normal and ischemic canine Purkinje fibers. J Cardiovasc Pharmacol 1981;3:881-95.
7. Kopia GA, Eller BT, Patterson E, Shea MJ, Lucchesi BR. Antiarrhythmic and electrophysiologic actions of clofilium in experimental canine models. Eur J Pharmacol 1985;116:49-61.
8. Boyden PA. Effects of pharmacologic agents on induced atrial flutter in dogs with right atrial enlargement. J Cardiovasc Pharmacol 1986;8:170-77.
9. Wu KM, Ross S, Huffman BF. Monophasic action potentials during reentrant atrial flutter in the dog: effects of clofilium and acectylcholine. J Cardiovasc Pharmacol 1989;13:908-14.
10. Patterson E, Scherlag BJ, Lazzara R. Electrophysiologic actions of clofilium and lidocaine in ischemically injured canine epicardium. J Pharmacol Exp Ther 1992;262:375-82.
11. Kowey PR, Friehling TD, O'Connor KM, Wetstein L, Kelliher GJ. The effect of bretylium and clofilium on dispersion of refractoriness and vulnerability to ventricular fibrillation in the ischemic feline heart. Am Heart J 1985;110:363-70.
12. Snyders DJ, Katzung BG. Clofilium reduces the plateau potassium current in isolated cardiac myocytes [Abstract]. Circulation 1985;72:III-233.
13. Arena JP, Kass RS. Block of heart potassium channels by clofilium and its tertiary analogs: relationship between drug structure and type of channel blocked. Mol Pharmacol 1988;34:60-6.
14. Kass RS, Arena JR, Walsh KB. Measurement and block of potassium channel currents in the heart: importance of channel type. Drug Dev Res 1990;19:115-27.
15. Argentieri TM, Carroll MS, Sullivan ME. Cellular electrophysiological effects of the class-III antiarrhythmic agents sematilide and clofilium on rabbit atrial tissues. J Cardiovasc Pharmacol 1991;18:167-74.
16. + channels by clofilium. Mol Pharmacol 1991;39:352-8.
17. Li T, Carr AA, Dage RC. Effects of MDL11,939 on action potential and contractile force in cardiac tissues: a comparison with bretylium, clofilium, and sotalol. J Cardiovasc Pharmacol 1990;16:917-23.
18. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 1981;391:85-100.
19. Isenberg G. Cardiac Purkinje fibers: Cs as a tool to block inward rectifying potassium currents. Pflugers Arch 1976;365:99-106.
20. + current. Differential sensitivity to block by class-III antiarrhythmic agents. J Gen Physiol 1990;96:195-215.
21. Sorota S, Boyden PA. Electrophysiology of the atrial myocardium. In: Dangman KH, Miura DS, eds. Electrophysiology and pharmacology of the heart. New York: Marcel Dekker, 1991:109-39.
22. Wettwer E, Scholtysik G, Schaad A, Himmel H, Ravens U. Effects of the new class-III antiarrhythmic drug E-4031 on myocardial contractility and electrophysiological parameters. J Cardiovasc Pharmacol 1991;17:480-7.
23. Reuter H. Calcium movements through cardiac cell membranes. Med Res Rev 1985;5:427-40.
24. Vaughan- Williams EM. A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 1984;24:129-47.
25. Courtney KR. Quantitative structure-activity relations based on use-dependent block and repriming kinetics in myocardium. J Moll Cell Cardiol 1987;19:319-30.
26. Hille B. Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor interaction. J Gen Physiol 1977;69:497-515.
27. Castle NA. Selective inhibition of potassium currents in rat ventricle by clofilium and tertiary homolog. J Pharmacol Exp Ther 1991;257:342-50.
28. + currents in neuroblastoma × glioma hybrid (NG 108-15) cells by clofilium, a class-III antidysrhythmic agent. Br J Pharmacol 1992;105:458-62.
29. + channel. Circ Res 1993;72:707-14.
30. + currents in Xenopus oocytes. Br J Pharmacol 1993;109:866-72.
31. 14C]- clofilium and its cardiac electrophysiological effect. J Pharmacol Exp Ther 1982;221:584-9.
32. sK channel from neonatal rat heart and diethylstilboestrol- primed rat uterus. Proc Natl Acad Sci USA 1990;87:2975-9.
33. + channel currents. Br J Pharmacol 1995;114:1222-6.
34. Malayev AA, Nelson DJ, Philipson LH. Mechanism of clofilium block of the human Kv1.5 delayed rectifier potassium channel. Mol Pharmacol 1995;47:198-205.
35. 1-adrenoceptors. Am J Physiol 1989;256:H1500-4.
36. 2+. Am J Physiol 1993;264:C1434-8.
37. Young HS, Skita V, Mason RP, Herbette LG. Molecular basis for the inhibition of 1,4-dihydropyridine calcium channel drugs binding to their receptors by a nonspecific site interaction mechanism. Biophys J 1992;61:1244-55.
38. Honerjäger P, Reiter M. The relation between the effects of veratridine on action potential and contraction in mammalian ventricular myocardium. Naunyn Schmiedebergs Arch Pharmacol 1975;289:1-28.